Dimensional Fund Advisors LP Cue Biopharma, Inc. Transaction History

Dimensional Fund Advisors LP

$363 Billion
Q1 2024

A detailed history of Dimensional Fund Advisors LP transactions in Cue Biopharma, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 431,308 shares of CUE stock, worth $534,821. This represents 0.0% of its overall portfolio holdings.

Number of Shares

431,308

Previous 457,985 5.82%

Holding current value

$534,821

Previous $1.21 Million 32.59%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$1.77 - $3.09 $47,218 - $82,431	-26,677 Reduced 5.82%	431,308 $815,000
Q4 2023 Feb 07, 2024	SELL	$1.72 - $3.1 $186,840 - $336,746	-108,628 Reduced 19.17%	457,985 $1.21 Million
Q3 2023 Nov 09, 2023	BUY	$2.23 - $4.69 $25,364 - $53,344	11,374 Added 2.05%	566,613 $1.3 Million
Q2 2023 Aug 09, 2023	BUY	$3.11 - $4.91 $29,902 - $47,209	9,615 Added 1.76%	555,239 $2.03 Million
Q1 2023 May 12, 2023	BUY	$2.41 - $3.74 $211,976 - $328,959	87,957 Added 19.22%	545,624 $1.95 Million

Q4 2022 Feb 09, 2023	BUY	$2.57 - $3.95 $8,982 - $13,805	3,495 Added 0.77%	457,667 $1.3 Million
Q3 2022 Nov 10, 2022	SELL	$2.45 - $3.37 $525,431 - $722,736	-214,462 Reduced 32.07%	454,172 $1.01 Million
Q2 2022 Aug 12, 2022	SELL	$2.49 - $5.92 $182,439 - $433,752	-73,269 Reduced 9.88%	668,634 $1.67 Million
Q1 2022 May 13, 2022	SELL	$4.41 - $12.28 $473,810 - $1.32 Million	-107,440 Reduced 12.65%	741,903 $3.62 Million
Q4 2021 Feb 09, 2022	BUY	$10.86 - $17.85 $7.22 Million - $11.9 Million	664,731 Added 360.07%	849,343 $9.61 Million
Q3 2021 Nov 12, 2021	BUY	$10.06 - $15.3 $1.05 Million - $1.59 Million	103,891 Added 128.7%	184,612 $2.69 Million
Q2 2021 Aug 12, 2021	BUY	$10.9 - $14.53 $879,858 - $1.17 Million	80,721 New	80,721 $940,000

Others Institutions Holding CUE

# of Institutions

Shares Held

16.3M

Call Options Held

12.9K

Put Options Held

39.1K

View Full List

About Cue Biopharma, Inc.

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $43.9M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

More about CUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Cue Biopharma, Inc. Transaction History